Results 261 to 270 of about 3,363,784 (294)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2007
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
European Urology, 2008
Patients with bladder cancer face a variable risk of recurrence based on their clinical characteristics and the biology of their disease. Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials.A MEDLINE literature search was ...
Shariat Shahrokh F. +4 more
openaire +2 more sources
Patients with bladder cancer face a variable risk of recurrence based on their clinical characteristics and the biology of their disease. Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials.A MEDLINE literature search was ...
Shariat Shahrokh F. +4 more
openaire +2 more sources
International Urogynecology Journal and Pelvic Floor Dysfunction, 1999
Bladder cancer is seen mainly in men. The incidence in women is increasing, but is still approximately three to four times lower than in men. In particular transitional cell cancers seem relatively more common in men then in women (ratio 4:1), but non-transitional cell cancer is also more frequent in men (ratio 2.7: 1).
Poel, H.G. van der +2 more
openaire +3 more sources
Bladder cancer is seen mainly in men. The incidence in women is increasing, but is still approximately three to four times lower than in men. In particular transitional cell cancers seem relatively more common in men then in women (ratio 4:1), but non-transitional cell cancer is also more frequent in men (ratio 2.7: 1).
Poel, H.G. van der +2 more
openaire +3 more sources
Lipomatosis of the bladder presenting as bladder cancer
International Journal of Urology, 2003Abstract A case of bladder lipomatosis in an 81‐year‐old man is presented. The preoperative diagnosis was bladder tumor. A transurethral resection of the bladder was performed and a pathological examination revealed lipomatosis of the bladder. This entity is extremely rare and, to our knowledge, this is the second case reported in the English published
Ozden, Tulunay +4 more
openaire +2 more sources
Bladder cancer: oligometastases and imaging
Nature Reviews Urology, 2017The term oligometastases was introduced to describe patients with limited metastatic disease in whom treatment might result in long-term disease-free survival or even cure. Imaging is pivotal for identification of these patients. The definition of oligometastatic bladder cancer and the optimal imaging modalities for diagnosis and response prediction ...
Mertens, Laura S, Horenblas, Simon
openaire +4 more sources
British Journal of Urology, 1985
Summary— We screened a series of 15 superficial and invasive transitional cell carcinomas of the bladder for transforming activity on the NIH/3T3 transfection assay. In addition, by obtaining tumour DNA and normal lymphocyte DNA from the same patients we looked for evidence of gene amplification or rearrangement
P R, Malone +4 more
openaire +2 more sources
Summary— We screened a series of 15 superficial and invasive transitional cell carcinomas of the bladder for transforming activity on the NIH/3T3 transfection assay. In addition, by obtaining tumour DNA and normal lymphocyte DNA from the same patients we looked for evidence of gene amplification or rearrangement
P R, Malone +4 more
openaire +2 more sources
JAAPA
Abstract: Bladder cancer, the 10th most common cancer globally, primarily manifests as urothelial cell carcinoma. Risk factors involve acquired genetic mutations and congenital predispositions, impacting diagnosis and management. This article discusses the risk factors, clinical presentation, and treatment strategies, with emphasis on ...
+7 more sources
Abstract: Bladder cancer, the 10th most common cancer globally, primarily manifests as urothelial cell carcinoma. Risk factors involve acquired genetic mutations and congenital predispositions, impacting diagnosis and management. This article discusses the risk factors, clinical presentation, and treatment strategies, with emphasis on ...
+7 more sources
Glycosylation in bladder cancer
International Journal of Clinical Oncology, 2008Complex carbohydrates are major components of the cell membrane and they play crucial roles in cell-cell and cell-extracellular matrix interactions, as well as in signal transduction. They consist of three kinds of molecular species; glycoproteins, proteoglycans, and glycosphingolipids.
openaire +2 more sources
Chemoprevention of bladder cancer
Urology, 2006Chemoprevention of cancer can be accomplished using primary, secondary, or tertiary strategies. Tertiary chemoprevention has been the predominant approach for bladder cancer and addresses the need for preventing the occurrence of second primary cancers in patients who have previously been treated for cancer.
openaire +2 more sources
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020William Oh +2 more
exaly